We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mycelx Technologies Corporation | LSE:MYX | London | Ordinary Share | COM SHS USD0.025 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 49.00 | 48.00 | 50.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Water Supply | 10.91M | -3.71M | -0.1612 | -3.10 | 11.26M |
TIDMMYX TIDMMYXR
RNS Number : 6252F
MyCelx Technologies Corporation
11 July 2023
11 July 2023
MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)
Contract Award
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company, is pleased to announce the award of a contract extension for wastewater treatment at a leading independent petrochemical facility in the Middle East.
This contract, together with the award announced on 3(rd) July 2023 for wastewater treatment in the Middle East, will generate revenue in aggregate in excess of $2 million in 2023 across the two contracts and helps underpin the current market forecast for the current year.
Connie Mixon, CEO, commented:
"Our technology and expertise continue to provide customers with effective solutions for treating complex process water. Maintaining the high level of performance that our customers require is extremely important to us and sets us apart from competitors."
For further information, please contact:
MYCELX Technologies Corporation Connie Mixon, CEO Tel: +1 888 306 6843 Kim Slayton, CFO Canaccord Genuity Limited (Nomad and Sole Broker) Henry Fitzgerald-O'Connor Tel: +44 20 7523 8000 Gordon Hamilton Celicourt Communications (Financial PR) Mark Antelme Tel: +44 20 7770 6424 Jimmy Lea
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
STRNKDBKPBKKOOD
(END) Dow Jones Newswires
July 11, 2023 02:00 ET (06:00 GMT)
1 Year Mycelx Technologies Chart |
1 Month Mycelx Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions